aTyr Pharma to Present at BIO CEO & Investor Conference
aTyr Pharma (Nasdaq: LIFE) announced that its President and CEO, Sanjay S. Shukla, will present a corporate overview at the BIO CEO & Investor Conference from February 14 to 17, 2022, at the Marriott Marquis, New York.
The presentation is scheduled for February 15, 2022, at 1:15 p.m. EST. Additionally, aTyr management will engage in both in-person and virtual one-on-one meetings during the conference. More information about aTyr's innovative biotherapeutics focusing on tRNA synthetases can be found at www.atyrpharma.com.
- None.
- None.
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the BIO CEO & Investor Conference, which is being held February 14 – 17, 2022, at the Marriott Marquis in New York, NY.
Dr. Shukla will present on Tuesday, February 15, 2022, at 1:15 p.m. EST.
Company management will also participate in in-person and virtual one-on-one meetings during the conference. Meetings can be scheduled through the conference partnering system or by contacting investorrelations@atyrpharma.com.
About aTyr
aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is efzofitimod, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to downregulate immune engagement in inflammatory lung diseases. For more information, please visit www.atyrpharma.com.
| Contact: |
| Ashlee Dunston |
| Director, Investor Relations and Corporate Communications |
| adunston@atyrpharma.com |
FAQ
What event is aTyr Pharma presenting at in February 2022?
Who will present on behalf of aTyr Pharma?
When is aTyr Pharma's presentation scheduled?
Where is the BIO CEO & Investor Conference taking place?
How can investors schedule meetings with aTyr Pharma during the conference?
